Parallel imports and price controls

RAND Journal of Economics

Volumn 39, Issue 2, 2008, Pages 378-402

  Grossman, Gene M ^a   L C Lai, Edwin ^b  

^a PRINCETON UNIVERSITY   (United States)

^b FEDERAL RESERVE BANK OF DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47649113932     PISSN: 07416261     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0741-6261.2008.00019.x     Document Type: Article

References (20)

1. ARFWEDSON, J. "Re-importation (Parallel Trade) in Pharmaceuticals." Institute for Policy Innovation Policy Report 182, IPI Center for Technology Freedom, 2004.
2. BARFIELD, C.E. AND GROOMBRIDGE, M.A. "The Economic Case for Copyright and Owner Control over Parallel Imports." Journal of World Intellectual Property, Vol. 1 (1998), pp. 903-939.
3. _,AND_,. "Parallel Trade in the Pharmaceutical Industry: Implications for Innovation, Consumer Welfare, and Health Policy." Fordham Intellectual Property, Media & Entertainment Law Journal, Vol. 10 (1999), pp. 185-265.
4. Cambridge Pharma Consultancy. Pricing and Reimbursement Review 2003. Cambridge, UK: IMS Health-Management Consulting, 2004.
5. CHARD, J.S. AND MELLOR, C.J. "Intellectual Property Rights and Parallel Imports." World Economy, Vol. 12 (1989), pp. 69-83.
6. DANZON, P.M. Pharmaceutical Price Regulation. Washington, DC: American Enterprise Institute Press, 1997.
7. _,"The Economics of Parallel Trade." PharmacoEconomics, Vol. 13 (1998), pp. 293-304.
8. _,AND TOWSE, A. "Differential Pricing for Pharmaceuticals: Reconciling Access, R & D and Patents." International Journal of Health Care Finance and Economics, Vol. 3 (2003), pp. 183-205.
9. GANSLANDT, M. AND MASKUS, K.E. "The Price Impact of Parallel Imports in Pharmaceuticals: Evidence from the European Union." Journal of Health Economics, Vol. 23 (2004), pp. 1035-1057.
10. GROSSMAN, G.M. AND LAI, E.L.-C. "International Protection of Intellectual Property." American Economic Review, Vol. 94 (2004), pp. 1635-1653.
11. KANAVOS, P. AND COSTA-FONT, J. "Pharmaceutical Parallel Trade in Europe: Stakeholder and Competition Effects." Economic Policy, Vol. 44 (2005), pp. 751-798.
12. LI, C. AND MASKUS, K.E. "The Impact of Parallel Imports on Investment in Cost-Reducing Research and Development." Journal of International Economics, Vol. 68 (2006), pp. 443-455.
13. MALUEG, D.A. AND SCHWARTZ, M. "Parallel Imports, Demand Dispersion, and International Price Discrimination." Journal of International Economics, Vol. 37 (1994), pp. 167-196.
14. MASKUS, K.E. Intellectual Property Rights in the Global Economy. Washington, DC: The Institute for International Economics, 2000a.
15. _,"Parallel Imports." World Economy, Vol. 23 (2000b), pp. 1269-1284.
16. _,"Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries." Final Report to the World Intellectual Property Organization, Geneva, 2001.
17. PECORINO, P. "Should the US Allow Prescription Drug Reimports from Canada?" Journal of Health Economics, Vol. 21 (2002), pp. 699-708.
18. REY, P. "The Impact of Parallel Imports on Prescription Medicines." Manuscript, University of Toulouse, 2003.
19. SZYMANSKI, S. AND VALLETTI, T. "Parallel Trade, Price Discrimination, Investment, and Price Caps." Economic Policy, Vol. 44 (2005), pp. 705-749.
20. VALLETTI, T.M. "Differential Pricing, Parallel Trade, and the Incentive to Invest." Journal of International Economics, Vol. 70 (2006), pp. 314-324.